Insights On Pharmaceutical Production
-
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
2/18/2025
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
-
Optimizing T-Cell Expansion Using DoE And Process Transfer
3/4/2025
Manufacturing CAR-T cells is challenging, but crucial. Discover how stirred culture systems paired with an innovative platform and software can accelerate development and enhance process understanding.
-
Automation Of iPSC Culture, Passaging, And Expansion
3/17/2025
Find out how iPSC-derived models enable researchers to generate diverse cell types and tissues as well as how automation reduces the labor-intensive culturing process with AI-powered decision-making.
-
API Solubility And Dissolution Enhancement Via Formulation
6/4/2025
Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.
-
A Closed And Automated Cell Therapy Manufacturing Solution
10/8/2024
Watch to explore the inner workings of a closed and automated solution that secures and standardizes cell activation, transduction, and expansion.
-
Balancing Protein A Resin Cost, Performance, And Productivity
7/31/2025
Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.
-
Digital Solutions Advance Your mRNA Manufacturing Workflow
6/17/2024
Explore the advantages of paperless manufacturing, the importance of incorporating a digital strategy early in the process, and how digital solutions for mRNA manufacturing can help enhance production.
-
Single-Step Purification Of A 21-mer Oligonucleotide Using Capto™ Q ImpRes Resin
1/13/2025
Explore how the oligonucleotide therapeutics market is advancing with scalable solutions for high-purity purification, supporting global production of life-changing RNA therapies.
-
EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging
8/27/2024
Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.
-
Cell Therapy Bioprocessing Workflow Cinematic
5/28/2025
Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.